The health care industry goes through a lot of supplies and one of the biggest providers of supplies is Becton Dickinson -- BDX -- NYSE. BDX is engaged principally in the manufacture and sale of a broad line of supplies, devices and systems used by health care professionals, medical research institutions and the general public. BDX's operations consist of three worldwide business segments: Medical Systems, Biosciences, and Preanalytical Solutions.
Don't expect spectacular rates of return but most analyst feel it will out perform the market. There are 11 analyst following this stock and only 1 feels it will under perform the market.
I found the stock by screening on BarChart for stocks trading over 100K shares a day that have hit new highs in at least 50% of the last 20 trading sessions. BDX has hit 12 new highs in the last 20 sessions and is recently 5 for 5. There has been a steady 12.36% price appreciation in the last 65 days. BarChart's technical analysis indicators have 12 buy signals out of 13 indicators with only 1 hold for a 96% Buy rating.
Although I have found BarChart to be dependable I always look to see what other sites think. Over on Wall Street Survivor Mark's checklist has Survivor Sentiment 5/5, Fundamentals 4/5, Technical 5/5 and Motley Fool at 5/4 for a 93% rating.
Over on Motley Fool they have 3 out/under perform ratios with the following results: All Members 654/14, All-Star Members 225/12 and their Wall Street ratio 14/0.
This stock has 3 things I look for in any stock recommendation:
- The stock is hitting new highs in at least 50% of the last 20 trading sessions and has at least an 80% buy rating on BarChart
- Has news buzz created by analysts from Wall Street and brokerage firms and do not have major negative outlooks
- Has confirmation of my choice from other sites -- If there is disagreement I always take a second look for why.
Recommendation: I'm buying Becton Dickinson BDX for my UpDown portfolio around 73.50 with a protective stop loss not less than 69.50.
Jim Van Meerten is an investor who writes on financial matters here and on Financial Tides. Please leave a comment below or email FinancialTides@gmail.com.
Disclosure: I do not hold any actual position in this stock at the time of publication.
No comments:
Post a Comment